• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TP53的突变破坏:一种理解化疗耐药性的结构方法。

Mutational Disruption of TP53: A Structural Approach to Understanding Chemoresistance.

作者信息

Alsulami Ali F

机构信息

Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

出版信息

Int J Mol Sci. 2025 Sep 18;26(18):9135. doi: 10.3390/ijms26189135.

DOI:10.3390/ijms26189135
PMID:41009698
Abstract

The tumour suppressor protein p53 plays a central role in safeguarding genomic integrity through the regulation of DNA repair, cell cycle arrest, and apoptosis. Mutations in , particularly within its DNA-binding domain, are among the most frequent genetic alterations in human cancers and are strongly associated with chemoresistance and poor prognosis. In this study, all TP53 mutations reported in the COSMIC database were systematically mapped onto all experimentally resolved TP53 three-dimensional structures available in the Protein Data Bank, supplemented with AlphaFold-predicted models to achieve full structural coverage. Mutations were classified according to their structural context-protein core, interface regions, ligand- and zinc-binding sites, and intrinsically disordered regions-and evaluated using complementary sequence- and structure-based predictive tools. The analysis revealed distinct mutational hotspots, differential distribution across structural regions, and context-dependent effects on stability and DNA-binding capacity. Notably, a subset of mutations exhibited consistent predictions of high destabilisation across all structural contexts, underscoring their potential as drivers of functional inactivation. By providing a comprehensive structural map of TP53 alterations, this work offers a valuable resource for understanding mutation-specific mechanisms of p53 dysfunction and for guiding the development of precision therapeutic strategies aimed at restoring its tumour-suppressive functions.

摘要

肿瘤抑制蛋白p53通过调节DNA修复、细胞周期停滞和凋亡在维护基因组完整性方面发挥核心作用。TP53的突变,尤其是其DNA结合域内的突变,是人类癌症中最常见的基因改变之一,并且与化疗耐药性和不良预后密切相关。在本研究中,COSMIC数据库中报告的所有TP53突变都被系统地映射到蛋白质数据库中所有实验解析的TP53三维结构上,并辅以AlphaFold预测模型以实现完整的结构覆盖。突变根据其结构背景进行分类——蛋白质核心、界面区域、配体和锌结合位点以及内在无序区域——并使用基于序列和结构的互补预测工具进行评估。分析揭示了不同的突变热点、跨结构区域的差异分布以及对稳定性和DNA结合能力的上下文依赖性影响。值得注意的是,一部分突变在所有结构背景下都表现出一致的高度去稳定化预测,突出了它们作为功能失活驱动因素的潜力。通过提供TP53改变的全面结构图,这项工作为理解p53功能障碍的突变特异性机制以及指导旨在恢复其肿瘤抑制功能的精准治疗策略的开发提供了宝贵资源。

相似文献

1
Mutational Disruption of TP53: A Structural Approach to Understanding Chemoresistance.TP53的突变破坏:一种理解化疗耐药性的结构方法。
Int J Mol Sci. 2025 Sep 18;26(18):9135. doi: 10.3390/ijms26189135.
2
Investigation of Structural Mechanisms Underlying p53 Dysfunction Caused by 148 Missense Mutations Using AlphaFold3 and Molecular Dynamics Simulations.使用AlphaFold3和分子动力学模拟研究148种错义突变导致p53功能障碍的结构机制
J Chem Inf Model. 2025 Jun 23;65(12):6322-6330. doi: 10.1021/acs.jcim.5c00580. Epub 2025 Jun 4.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Shoulder Arthrogram肩关节造影
5
Vesicoureteral Reflux膀胱输尿管反流
6
Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma.全面的突变分析确定了皮肤平滑肌肉瘤中的新驱动事件。
Br J Dermatol. 2025 Jan 24;192(2):335-343. doi: 10.1093/bjd/ljae386.
7
TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database.TP53 突变作为特定癌症潜在的预后标志物:来自癌症基因组图谱和国际癌症研究机构 TP53 数据库的数据分析。
J Cancer Res Clin Oncol. 2019 Mar;145(3):625-636. doi: 10.1007/s00432-018-2817-z. Epub 2018 Dec 12.
8
Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review.宫颈癌腺癌和鳞癌中 TP53 基因突变:系统评价。
Gynecol Oncol. 2013 Mar;128(3):442-8. doi: 10.1016/j.ygyno.2012.11.017. Epub 2012 Nov 17.
9
Correlating p53 immunostaining patterns with somatic TP53 mutation and functional properties of mutant p53 in triple-negative breast cancer.三阴乳腺癌中p53免疫染色模式与体细胞TP53突变及突变型p53功能特性的相关性
Histopathology. 2025 Aug;87(2):299-309. doi: 10.1111/his.15453. Epub 2025 Mar 31.
10
Correlative Assessment of p53 Immunostaining Patterns and TP53 Mutation Status by Next-Generation Sequencing in High-Grade Endometrial Carcinomas.高级别子宫内膜癌中 p53 免疫组化模式与下一代测序 TP53 基因突变状态的相关性评估。
Int J Gynecol Pathol. 2023 Nov 1;42(6):567-575. doi: 10.1097/PGP.0000000000000930. Epub 2022 Nov 15.

本文引用的文献

1
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI.失调的p53反式激活结构域是FOXO4和衰老细胞溶解化合物FOXO4-DRI的作用靶点。
Nat Commun. 2025 Jul 1;16(1):5672. doi: 10.1038/s41467-025-60844-9.
2
Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer.利用TP53热点突变作为非小细胞肺癌中吉西他滨治疗结果的有效预测指标。
Cell Death Discov. 2025 Jan 27;11(1):26. doi: 10.1038/s41420-025-02300-7.
3
Comprehensive annotation of mutations in hallmark genes insights into structural and functional implications.
对标志性基因中突变的全面注释有助于深入了解其结构和功能意义。
Comput Biol Med. 2025 Feb;185:109588. doi: 10.1016/j.compbiomed.2024.109588. Epub 2024 Dec 19.
4
TP53 mutations in cancer: Molecular features and therapeutic opportunities (Review).TP53 基因突变与癌症:分子特征与治疗机会(综述)。
Int J Mol Med. 2025 Jan;55(1). doi: 10.3892/ijmm.2024.5448. Epub 2024 Oct 25.
5
Mut-Map: Comprehensive Computational Pipeline for Structural Mapping and Analysis of Cancer-Associated Mutations.Mut-Map:用于癌症相关突变的结构映射和分析的综合计算流程。
Brief Bioinform. 2024 Sep 23;25(6). doi: 10.1093/bib/bbae514.
6
Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation.人工智能 alphafold 模型在分子生物学和药物发现中的应用:基于机器学习的信息学研究。
Mol Cancer. 2024 Oct 5;23(1):223. doi: 10.1186/s12943-024-02140-6.
7
Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance.p53 异构体的规范和非规范功能:增强肿瘤发展和治疗耐药性的复杂性。
Cell Death Dis. 2024 Jun 12;15(6):412. doi: 10.1038/s41419-024-06783-7.
8
TP53 mutation promotes breast cancer cell proliferation through CORO1A-P38 MAPK pathway regulation.TP53 突变通过 CORO1A-P38 MAPK 通路调控促进乳腺癌细胞增殖。
Biochem Pharmacol. 2024 Mar;221:116047. doi: 10.1016/j.bcp.2024.116047. Epub 2024 Feb 7.
9
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response.突变型 p53 通过染色体不稳定诱导的细胞质 DNA 反应获得致癌功能。
Nat Commun. 2024 Jan 2;15(1):180. doi: 10.1038/s41467-023-44239-2.
10
Accurate proteome-wide missense variant effect prediction with AlphaMissense.使用 AlphaMissense 进行精确的全蛋白质错义变异效应预测。
Science. 2023 Sep 22;381(6664):eadg7492. doi: 10.1126/science.adg7492.